Research Article
The Relationship of CSF and Plasma Cytokine Levels in HIV Infected Patients with Neurocognitive Impairment
Table 1
Demographic and disease characteristics of subjects.
| | Characteristics | HIV-CI | HIV-NC | value |
| | Number of subjects | 52 | 33 | | | Age in years [median (IQR)] | 38 (31–42) | 38 (33–42) | | | Gender [ (%)] | | | | | Male | 38 (73%) | 21 (64%) | | | Female | 14 (27%) | 12 (36%) | | | HIV RNA ( copies/mL) [median (IQR)] | | | | | CSF | 4.50 (2.95–7.50) | 3.06 (1.70–3.60) | | | Plasma | 5.915 (3.44–7.50) | 3.905 (2.70–5.21) | | | CD4+ cell count (cell/μL) [median (IQR)] | 41 (21–120) | 69 (21–120) | | | CSF | | | | | Cell count (cell/μL) [median (IQR)] | 12 (6–21) | 11 (7–30) | | | Protein (mg/mL) [median (IQR)] | 74 (73–110) | 41 (34–48) | | | Number of threated by HAART [ (%)] | 20 (38.5) | 17 (51.5) | | | Treatment duration (months) [median (range)] | 4 (2–6) | 6 (2–18) | | | CNS complications [ (%)] | 17 (33%) | 12 (36%) | |
|
|
